Publications Clinical Highlights: December 2024 Your monthly source for drug information highlights. December 30, 2024 Weight Management Corner An analysis published in The Lancet details national-...

publications High-Cost Therapy Profile: July 2025 Rebisufligene etisparvovec Intravenous (IV) Metabolic gene therapy July 3, 2025 Proposed indications Sanfilippo A syndrome (Mucopolysaccharidosis...

publications Trending Topics & Drug Approvals: June 2025 Your source for the latest drug information highlights July 1, 2025 Trending Topics Hot topics On June 9, 2025, the United States (U.S.)...

This monthly approval update provides a review of newly approved specialty drugs, recent drug launches, generic updates, new indications and news of note on drugs in the approval process.

A roundup of Prime's award-winning presentations and insights at AMCP Nexus in National Harbor, Maryland

publications High-Cost Therapy Profile: August 2025 Apitegromab Intravenous (IV) | Scholar Rock, LLC Neuromuscular August 15, 2025 Proposed indications Spinal muscular atrophy (SMA) FDA...

Perspectives High-Cost Therapy Profile: January Detailed information about Atidarsagene Autotemcel Intravenous (IV) High Cost Therapy Profile Atidarsagene Autotemcel Intravenous (IV) Orchard ...

publications ASCO 2025 Spotlight: The Trials Making Headlines July 14, 2025 Author: Abby Kim, PharmD, BCOP The 2025 American Society of Clinical Oncology (ASCO) annual meeting lived up to its...